Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 02196.HK) announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial...
Hence then, the article about fosun pharma received nmpa approval for wan ti le tenapanor hydrochloride tablets was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets) )
Also on site :
- Another Weight Loss Surgery and a Wedding Bombshell: Spoilers From '1000-Lb Sisters' Season 8 Episode 2
- Trump-Iran latest: President threatens ‘very strong action’ if protesters are hanged after forced confessions
- High Potential Finally Explores Morgan And Ludo's Breakup, But EP Says There's More To The Story: 'It's Complicated'